{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T22:31:05Z","timestamp":1792794665942,"version":"4.5.0"},"reference-count":31,"publisher":"American Medical Association (AMA)","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"DOI":"10.1001\/jamanetworkopen.2021.18487","type":"journal-article","created":{"date-parts":[[2021,8,27]],"date-time":"2021-08-27T11:33:39Z","timestamp":1630064019000},"page":"e2118487","source":"Crossref","is-referenced-by-count":59,"title":["Mobile Telemedicine for Buprenorphine Treatment in Rural Populations With Opioid Use Disorder"],"prefix":"10.1001","volume":"4","author":[{"given":"Eric","family":"Weintraub","sequence":"first","affiliation":[{"name":"Division of Addiction Research and Treatment, Department of Psychiatry, University of Maryland School of Medicine, Baltimore"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chamindi","family":"Seneviratne","sequence":"additional","affiliation":[{"name":"Division of Addiction Research and Treatment, Department of Psychiatry, University of Maryland School of Medicine, Baltimore"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Anane","sequence":"additional","affiliation":[{"name":"Division of Addiction Research and Treatment, Department of Psychiatry, University of Maryland School of Medicine, Baltimore"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly","family":"Coble","sequence":"additional","affiliation":[{"name":"Division of Addiction Research and Treatment, Department of Psychiatry, University of Maryland School of Medicine, Baltimore"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Magidson","sequence":"additional","affiliation":[{"name":"Department of Psychology, University of Maryland, College Park"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Kattakuzhy","sequence":"additional","affiliation":[{"name":"Division of Critical Care and Research, Institute of Human Virology, Division of Infectious Disease, University of Maryland School of Medicine, Baltimore"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aaron","family":"Greenblatt","sequence":"additional","affiliation":[{"name":"Division of Addiction Research and Treatment, Department of Psychiatry, University of Maryland School of Medicine, Baltimore"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Welsh","sequence":"additional","affiliation":[{"name":"Division of Addiction Research and Treatment, Department of Psychiatry, University of Maryland School of Medicine, Baltimore"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Pappas","sequence":"additional","affiliation":[{"name":"Division of Addiction Research and Treatment, Department of Psychiatry, University of Maryland School of Medicine, Baltimore"},{"name":"Now with Venice Family Clinic, Venice, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Terri L.","family":"Ross","sequence":"additional","affiliation":[{"name":"Caroline County Health Department, Denton, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annabelle M.","family":"Belcher","sequence":"additional","affiliation":[{"name":"Division of Addiction Research and Treatment, Department of Psychiatry, University of Maryland School of Medicine, Baltimore"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2021,8,27]]},"reference":[{"issue":"3","key":"zoi210547r1","doi-asserted-by":"crossref","first-page":"e26","DOI":"10.2105\/AJPH.2014.302520","article-title":"Disparity in naloxone administration by emergency medical service providers and the burden of drug overdose in US rural communities.","volume":"105","author":"Faul","year":"2015","journal-title":"Am J Public Health"},{"issue":"12","key":"zoi210547r2","doi-asserted-by":"publisher","first-page":"3241","DOI":"10.1111\/ajt.14555","article-title":"Illicit drug use, illicit drug use disorders, and drug overdose deaths in metropolitan and nonmetropolitan areas\u2014United States.","volume":"17","author":"Mack","year":"2017","journal-title":"Am J Transplant"},{"issue":"2","key":"zoi210547r3","article-title":"Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence.","author":"Mattick","year":"2003","journal-title":"Cochrane Database Syst Rev"},{"issue":"2","key":"zoi210547r4","article-title":"Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence.","author":"Mattick","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"issue":"3","key":"zoi210547r5","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1080\/00952990.2019.1694536","article-title":"A systematic review of rural-specific barriers to medication treatment for opioid use disorder in the United States.","volume":"46","author":"Lister","year":"2020","journal-title":"Am J Drug Alcohol Abuse"},{"issue":"1","key":"zoi210547r6","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1370\/afm.1735","article-title":"Geographic and specialty distribution of US physicians trained to treat opioid use disorder.","volume":"13","author":"Rosenblatt","year":"2015","journal-title":"Ann Fam Med"},{"issue":"4","key":"zoi210547r7","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1370\/afm.2099","article-title":"Barriers rural physicians face prescribing buprenorphine for opioid use disorder.","volume":"15","author":"Andrilla","year":"2017","journal-title":"Ann Fam Med"},{"issue":"1","key":"zoi210547r8","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1111\/jrh.2019.35.issue-1","article-title":"Geographic distribution of providers with a DEA waiver to prescribe buprenorphine for the treatment of opioid use disorder: a 5-year update.","volume":"35","author":"Andrilla","year":"2019","journal-title":"J Rural Health"},{"key":"zoi210547r9","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2020.108131","article-title":"Geographic proximity to buprenorphine treatment providers in the U.S.","volume":"213","author":"Langabeer","year":"2020","journal-title":"Drug Alcohol Depend"},{"issue":"1","key":"zoi210547r10","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1001\/jama.2020.3940","article-title":"Treating patients with opioid use disorder in their homes: an emerging treatment model.","volume":"324","author":"Uscher-Pines","year":"2020","journal-title":"JAMA"},{"issue":"2","key":"zoi210547r11","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1377\/hlthaff.2018.05435","article-title":"Telemedicine in substance use disorder treatment.","volume":"38","author":"Barash","year":"2019","journal-title":"Health Aff (Millwood)"},{"issue":"8","key":"zoi210547r12","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1111\/ajad.v27.8","article-title":"Expanding access to buprenorphine treatment in rural areas with the use of telemedicine.","volume":"27","author":"Weintraub","year":"2018","journal-title":"Am J Addict"},{"issue":"2","key":"zoi210547r13","first-page":"5","article-title":"Outcomes for patients receiving telemedicine-delivered medication-based treatment for opioid use disorder: a retrospective chart review.","volume":"23","author":"Weintraub","year":"2021","journal-title":"Heroin Addict Relat Clin Probl"},{"issue":"4","key":"zoi210547r15","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1016\/j.jsat.2013.11.002","article-title":"Mobile opioid agonist treatment and public funding expands treatment for disenfranchised opioid-dependent individuals.","volume":"46","author":"Hall","year":"2014","journal-title":"J Subst Abuse Treat"},{"key":"zoi210547r16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jsat.2019.05.002","article-title":"Expanding low-threshold buprenorphine to justice-involved individuals through mobile treatment: addressing a critical care gap.","volume":"103","author":"Krawczyk","year":"2019","journal-title":"J Subst Abuse Treat"},{"issue":"6","key":"zoi210547r17","doi-asserted-by":"publisher","first-page":"466","DOI":"10.4037\/ajcc2015455","article-title":"Squire 2.0 (Standards for Quality Improvement Reporting Excellence): revised publication guidelines from a detailed consensus process.","volume":"24","author":"Ogrinc","year":"2015","journal-title":"Am J Crit Care"},{"issue":"3","key":"zoi210547r18","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.ymeth.2004.08.013","article-title":"Mass spectrometry of peptides and proteins.","volume":"35","author":"Wysocki","year":"2005","journal-title":"Methods"},{"issue":"2","key":"zoi210547r19","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","article-title":"Research electronic data capture (REDCap): a metadata-driven methodology and workflow process for providing translational research informatics support.","volume":"42","author":"Harris","year":"2009","journal-title":"J Biomed Inform"},{"issue":"5","key":"zoi210547r20","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.5734","article-title":"Assessment of racial and ethnic disparities in the use of medication to treat opioid use disorder among pregnant women in Massachusetts.","volume":"3","author":"Schiff","year":"2020","journal-title":"JAMA Netw Open"},{"issue":"1","key":"zoi210547r21","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1186\/s12888-016-0819-4","article-title":"Determinants of dropout in a community-based mental health crisis centre.","volume":"16","author":"Henzen","year":"2016","journal-title":"BMC Psychiatry"},{"issue":"11","key":"zoi210547r22","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1111\/j.1525-1497.2005.0228.x","article-title":"Buprenorphine retention in primary care.","volume":"20","author":"Stein","year":"2005","journal-title":"J Gen Intern Med"},{"issue":"1","key":"zoi210547r23","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1111\/dar.2012.31.issue-1","article-title":"Retention, early dropout and treatment completion among therapeutic community admissions.","volume":"31","author":"Darke","year":"2012","journal-title":"Drug Alcohol Rev"},{"key":"zoi210547r24","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.jsat.2015.04.010","article-title":"Prior experience with non-prescribed buprenorphine: role in treatment entry and retention.","volume":"57","author":"Monico","year":"2015","journal-title":"J Subst Abuse Treat"},{"key":"zoi210547r25","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsat.2020.108073","article-title":"Chronic prescription opioid use predicts stabilization on buprenorphine for the treatment of opioid use disorder.","volume":"117","author":"Varisco","year":"2020","journal-title":"J Subst Abuse Treat"},{"key":"zoi210547r26","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2020.108317","article-title":"Adherence to buprenorphine: an analysis of prescription drug monitoring program data.","volume":"216","author":"Pizzicato","year":"2020","journal-title":"Drug Alcohol Depend"},{"issue":"1","key":"zoi210547r27","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1080\/10550887.2011.642758","article-title":"Effect of buprenorphine dose on treatment outcome.","volume":"31","author":"Fareed","year":"2012","journal-title":"J Addict Dis"},{"issue":"23","key":"zoi210547r28","doi-asserted-by":"publisher","first-page":"2202","DOI":"10.1056\/NEJMp2025331","article-title":"\u201cWhen will we have a vaccine?\u201d understanding questions and answers about Covid-19 vaccination.","volume":"383","author":"Bloom","year":"2020","journal-title":"N Engl J Med"},{"issue":"1","key":"zoi210547r29","doi-asserted-by":"publisher","first-page":"57","DOI":"10.7326\/M20-1141","article-title":"An epidemic in the midst of a pandemic: opioid use disorder and COVID-19.","volume":"173","author":"Alexander","year":"2020","journal-title":"Ann Intern Med"},{"issue":"4","key":"zoi210547r30","doi-asserted-by":"publisher","first-page":"268","DOI":"10.7326\/M16-2149","article-title":"Primary care-based models for the treatment of opioid use disorder: a scoping review.","volume":"166","author":"Korthuis","year":"2017","journal-title":"Ann Intern Med"},{"issue":"4","key":"zoi210547r31","article-title":"Decision aids for people facing health treatment or screening decisions.","volume":"4","author":"Stacey","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"zoi210547r14","unstructured":"University of Maryland Shore Regional Health. Community health needs assessment and implementation plan. Published 2019. Accessed July 30, 2021. https:\/\/www.umms.org\/shore\/community\/assessment-implementation-plan"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2783548\/weintraub_2021_oi_210547_1629491515.07032.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,27]],"date-time":"2021-08-27T11:33:54Z","timestamp":1630064034000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2783548"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,27]]},"references-count":31,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2021,8,2]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2021.18487","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8,27]]}}}